Compulsory licensure: the case of Cipro and beyond.
Chakrabarty
Ananda M
AM
University of Illinois at Chicago.
D000881:Anthrax / Q000188:drug therapy; D023482:Bioterrorism; D002939:Ciprofloxacin / Q000600:supply & distribution / Q000627:therapeutic use; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence; D033041:Embryo Research; D035082:Federal Government; D006801:Humans; D038622:Internationality; D008004:Licensure / Q000331:legislation & jurisprudence*; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D004364:Pharmaceutical Preparations / Q000191:economics / Q000600:supply & distribution; D011640:Public Policy; D013234:Stem Cells; D014481:United States
D004364:Pharmaceutical Preparations; D002939:Ciprofloxacin